Euronext – Q2 2024 results
AstraZeneca – ODAC reviewed Imfinzi in resectable lung cancer
HICL Infrastructure – Interim Update
RELX – Interim Results
Young & Co’s Brewery – AGM Trading Update
AstraZeneca Plc – Half Year Results
Lloyds Banking Group – Half Year Results
